15-51683095-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013243.4(SCG3):āc.152A>Gā(p.Glu51Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,457,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013243.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCG3 | NM_013243.4 | c.152A>G | p.Glu51Gly | missense_variant | 3/12 | ENST00000220478.8 | NP_037375.2 | |
SCG3 | NM_001165257.2 | c.-545A>G | 5_prime_UTR_variant | 2/11 | NP_001158729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCG3 | ENST00000220478.8 | c.152A>G | p.Glu51Gly | missense_variant | 3/12 | 1 | NM_013243.4 | ENSP00000220478.3 | ||
SCG3 | ENST00000542355.6 | c.-545A>G | 5_prime_UTR_variant | 2/11 | 2 | ENSP00000445205.2 | ||||
SCG3 | ENST00000558709.1 | c.-402A>G | 5_prime_UTR_variant | 2/5 | 2 | ENSP00000452745.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248186Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134468
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1457932Hom.: 0 Cov.: 29 AF XY: 0.00000551 AC XY: 4AN XY: 725546
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2023 | The c.152A>G (p.E51G) alteration is located in exon 3 (coding exon 3) of the SCG3 gene. This alteration results from a A to G substitution at nucleotide position 152, causing the glutamic acid (E) at amino acid position 51 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at